Synlab MyEdit-B Test

Synlab has launched the MyEdit-B blood-based test to differentially diagnose bipolar disorder from unipolar depression. The test results from a collaboration between Synlab and diagnostics manufacturer Alcediag and is being piloted in Italy. It also is available in other countries through the Synlab network. MyEdit-B, which was CE-IVD certified in May, uses RNA-editing biomarkers. After a blood sample is RNA sequenced, the MyEdit-B algorithm analyzes the RNA editing of genes involved in mechanisms associated with mood disorders. Results are achieved within 24 days, Synlab said.